TCL Archive FDA Committee Okays Leuprolide NDA, But Recommends Against Mitoxantrne, Epirubicin April 5, 1985
TCL Archive NCI’s use of Cancer Dialogue for biospecimen network blueprint raises legal, procedural questions. December 12, 2003
TCL Archive NCI Plans $30 Million In Patient-Oriented Chemoprevention research In Next 5 Years December 6, 1996